IperionX
IPX
8 hedge funds and large institutions have $5.45M invested in IperionX in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
335% more capital invested
Capital invested by funds: $1.25M → $5.45M (+$4.2M)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
33% more funds holding
Funds holding: 6 → 8 (+2)
0.24% more ownership
Funds ownership: 0.14% → 0.38% (+0.24%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BRF
B. Riley Financial
Los Angeles,
California
|
+$2.99M |
| 2 |
Jane Street
New York
|
+$330K |
| 3 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$22.2K |
| 4 |
Barclays
London,
United Kingdom
|
+$17.5K |
| 5 |
PG
Proffitt & Goodson
Knoxville,
Tennessee
|
+$2.04K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.11K |
| 2 |
Morgan Stanley
New York
|
-$512 |
IPX Hedge Fund Activity: Q2 2023 in Review
8 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in IperionX (IPX) for Q2 2023, worth a combined $5.45M — up 335% from $1.25M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new IPX positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was B. Riley Financial, opening a new position worth an estimated $2.99M. The largest seller was UBS Group, exiting entirely with an estimated $1.11K sold.
- 8 institutional investors held IperionX (IPX) as of Q2 2023, up from 6 in Q1 2023.
- Funds reported $5.45M of IperionX stock for Q2 2023, up 335% quarter-over-quarter.
- 4 funds opened new IperionX positions in Q2 2023 and 2 closed out, a net change of +2 holders.
- The largest IperionX buyer in Q2 2023 was B. Riley Financial, an estimated $2.99M added.
- The largest IperionX seller in Q2 2023 was UBS Group, an estimated $1.11K sold.
Based on aggregated 13F filings for Q2 2023.